Skip to main content

Intestinal Vaginoplasty (Sigmoid / Ileum / Right Colon)

Intestinal vaginoplasty uses a pedicled segment of bowel — most commonly sigmoid colon, less commonly ileum or right colon — to construct a self-lubricating neovaginal canal with consistent depths of 14–17 cm and persistent mucus-secreting mucosa that does not undergo metaplasia.[1][2][3] It serves both as a primary procedure (55.5% of cases in the largest series) and as a revision / salvage procedure (44.5%) for failed penile inversion vaginoplasty (PIV).[1] The largest contemporary single-centre series (Lava 2025) encompasses 119 patients with an overall complication rate of 33%, reoperation rate 16.8–18%, and 2 reported mortalities across the cumulative literature.[1][4]

This is the dedicated atlas page. For the cohort-level decision framework, see Feminizing Gender-Affirming Surgery. For the skin-lined gold standard, see Penile Inversion Vaginoplasty. For the principal alternative for insufficient donor tissue, see Peritoneal Pull-Through Vaginoplasty.

Historical Context and Technical Evolution​

Intestinal vaginoplasty was first described in cisgender vaginal-agenesis cohorts in the early 20th century and adapted to transfeminine GAS in the 1970s–80s via open laparotomy.[5] Evolutionary milestones:

  • Open abdominoperineal era — large incisions, prolonged hospitalisation, significant morbidity.[5]
  • Total laparoscopic sigmoid vaginoplasty (Amsterdam / VUmc, 2008–present) — Bouman, Meijerink, and van der Sluis matured the minimally invasive approach (42 primary + 21 secondary procedures with no conversions to laparotomy).[6]
  • 3D laparoscopic technique (Kim 2021) — mean depth 15.2 cm in n = 17.[7]
  • Robot-assisted (Kim 2026; Sljivich 2025) — Kim n = 12 mean depth 14.6 cm; Sljivich n = 36 mean depth 17.6 cm with LOS 3.7 d (substantially shorter than laparoscopic series).[8][2]
  • ICG fluorescence-guided perfusion assessment — Flor-Lorente 2021 and van der Sluis 2019 use indocyanine green fluorescent angiography to confirm perfusion of the pedicled sigmoid; one of six cases in the original ICG series had inadequate vascularisation leading to aborted reconstruction.[9][10]

Indications​

SettingIndicationsAnchor
Primary vaginoplastyPenoscrotal hypoplasia (pubertal suppression, radical circumcision, prior orchiectomy, naturally small genitalia); patient preference for self-lubrication / reduced dilation / greater depth; higher BMI with limited perineal accessLava 2025[1]; van der Sluis 2019[12]; Bene 2024[13]
Revision / salvageFailed primary PIV with complete stenosis, inadequate depth, or canal loss; failed peritoneal vaginoplastyLava 2025[1]; Robinson SR[4]; van der Sluis 2019[12]
  • di Summa 2019 — 30.2% (13/43) of patients who initially underwent PIV required secondary sigmoid vaginoplasty, primarily for insufficient depth.[14]
  • Lava 2025 — 44.5% of 119 patients were revision cases, with complication rates similar between primary and revision cohorts.[1]

Surgical Technique​

Combined abdominoperineal operation, typically two-team:[6][9]

Perineal phase (reconstructive surgeon):

  1. Bilateral orchiectomy (if not previously done).
  2. Penile disassembly — degloving, dorsal-NVB preservation with the glans for clitoroplasty, corpora cavernosa excision.
  3. Urethral shortening and repositioning.
  4. Neovaginal cavity dissection between rectum and bladder/prostate, meeting the abdominal dissection.
  5. Vulvar construction — clitoroplasty, clitoral hood, labia minora, labia majora.

Abdominal phase (colorectal / laparoscopic surgeon):

  1. Ports — laparoscopic (3–4) or robotic (da Vinci Xi).
  2. Sigmoid mobilisation — identify a 12–15 cm segment (up to 30 cm in some techniques).
  3. Vascular pedicle — based on sigmoid arteries (IMA branches); ICG angiography confirms perfusion.[9][10]
  4. Segment isolation — endoscopic staplers at both ends; vascular pedicle preserved.
  5. Orientation — isoperistaltic (most common) or antiperistaltic (used to optimise pedicle geometry in selected cases).[6][9]
  6. Colovestibular anastomosis — distal staple line opened and interdigitated to perineal skin / inverted penile skin.[6]
  7. Length tailoring — measured with transilluminated dildo / conformer; stapled at the apex.[6]
  8. Neovaginopexy — apex fixed to the sacral promontory to prevent prolapse.[6]
  9. Bowel continuity — intra-abdominal side-to-side oversewn stapled anastomosis.[6]
  10. Vaginal stent / conformer placement.

Robot-assisted modification (Kim 2026; Sljivich 2025): da Vinci Xi for flap preparation and canal dissection; OR time 272.9 min (Sljivich) to 544.8 min (Kim); LOS 3.7 d (Sljivich); mean depth 14.6–17.6 cm.[8][2]

Operative Parameters​

ParameterAmsterdam laparoscopic3D laparoscopic (Kim)Robot (Kim)Robot (Sljivich)Largest series (Lava)
n63 (42 primary, 21 revision)171236119 (66 primary, 53 revision)
OR timeNot reported529 ± 128 min544.8 min272.9 min209 min primary / 162 min revision
Neovaginal depthNot reported15.2 ± 1.3 cm14.6 cm17.6 cmNot reported
Length of stayNot reportedNot reportedNot reported3.7 dNot reported
Complication rate7.9% major5.9% 30-day readmission41.7%Not reported17.7% short-term / 24.4% long-term

Anchors: Bouman 2016[6]; Kim 2021[7]; Kim 2026[8]; Sljivich 2025[2]; Lava 2025[1].

Choice of Bowel Segment​

FeatureSigmoidIleumRight colon (cecum)
DiameterLarge (matches vaginal caliber)Small (may be too narrow)Large
Mucus productionModerateExcessive (mitigable with technique)Moderate
Mesenteric reachShorterLong (excellent perineal reach)Long (ileocolic)
Vascular pedicleReliable (sigmoid arteries)SMA branches; variableReliable (ileocolic artery)
Stenosis (surgical correction)4.1%1.2%18% (4/22)
Prolapse6–11.8%Lower22.7% (5/22)
StatusStandard (primary + revision)Niche; predominantly revision / salvage (90.6% of multicenter cohort)Emerging alternative

Sigmoid is canonical — adequate diameter, reliable pedicle, manageable mucus, perineal proximity.[5][3] Ileum has historically been disfavoured for excessive mucus production and small luminal caliber, but several technical modifications (Schneider J-pouch, Trombetta Monti retubularization, Ozkan free jejunal flap, Cho free jejunal graft) directly address these limitations — see the dedicated ileal-variants section below.[5][37][38][39][40] Right colon (Garcia 2021, n = 22) has theoretical advantages (long ileocolic pedicle, native cecal blind pouch eliminating apex staple line, appendix as landmark) but the only outcomes series showed 22.7% prolapse and 18% stenosis.[15]

Ileal Vaginoplasty — Variants, Outcomes, and Current Role​

Ileal vaginoplasty is used predominantly as a revision / salvage procedure — 90.6% (29/32) in the largest international multicentre series (van der Sluis 2018) — for failed primary PIV with complete neovaginal stenosis or inadequate depth, or when sigmoid is unavailable (prior resection, pathology).[37][12] The largest dedicated ileal series are Zhao YZ 2011 (n = 82, laparoscope-assisted pedicled ileum) and van der Sluis 2018 (n = 32 international multicentre).[37][41]

Rationale and resurgence​

Ileum was among the earliest intestinal segments used (Baldwin loop, early 20th century). The long mesentery provides excellent perineal reach — a structural advantage over sigmoid in patients with challenging pelvic anatomy or prior pelvic surgery — but excessive mucus secretion from the higher goblet-cell density of small bowel and small luminal caliber (2–3 cm) drove most centres toward sigmoid by the late 20th century.[5][37] Several modern modifications address these limitations directly.[37][38][39][40][42]

Variants​

A. Standard pedicled ileal segment (single lumen) — the most common variant (27/32 in van der Sluis 2018). Distal-ileal 12–15 cm segment isolated on a mesenteric pedicle (SMA branches) ~ 15–20 cm proximal to the ileocecal valve, transposed caudally through the neovaginal tunnel; open end sutured to perineal skin (ileocutaneous anastomosis); ileo-ileal continuity restored. Open laparotomy (25/32) or laparoscopic (7/32).[37]

B. Ileal U-pouch — two adjacent ileal segments folded into a U-configuration and anastomosed side-to-side to create a wider lumen, directly addressing the single-lumen caliber problem (5/32 in van der Sluis 2018).[37]

C. Ileal J-pouch (Schneider 2009) — terminal-ileum J-pouch pedicled on the ileocolic artery and accompanying nervous plexus. Terminal ileum is chosen specifically for its balanced fluid resorption and mucus secretion, reducing discharge while preserving lubrication. At 1-year follow-up: adequate vaginal size, optimal lubrication, no fecal odor.[38]

D. Transverse retubularized ileal vaginoplasty — Monti principle (Trombetta / Trieste 2005) — applies the Monti channel principle (originally for continent urinary diversion) to vaginal reconstruction: ileal segment isolated on its mesenteric pedicle, longitudinally detubularized along the antimesenteric border, then transversely retubularized perpendicular to its original axis to create a wider-caliber tube from a shorter segment. n = 6, mean follow-up 16 mo; OR time 220 min; no intraoperative complications; all patent moist neovaginas; excessive mucus was not a problem in any patient — suggesting that reducing mucosal surface area attenuates secretions. Used to configure the apex.[39][43]

E. Laparoscope-assisted pedicled-ileum transfer (Zhao YZ 2011, the largest series) — n = 82 (2002–2010). Simultaneous abdominal-perineal approach; ileal segment harvested and transposed under laparoscopic guidance; silicone vaginal tutor maintained continuously for 2–3 months postoperatively. Mean depth 15 cm, width 3.2 cm. Complications in 16/82 (19.5%) — rectal / bladder injury, acute renal failure, delayed ileocutaneous-anastomosis healing, introital stenosis, partial / complete bowel obstruction. Neovagina described as patent, soft, moist, and flexible.[41]

F. Free jejunal graft vaginoplasty (Cho / Korea 2025) — novel two-stage technique using a free (non-pedicled) jejunal segment with microvascular anastomosis. Stage 1: orchiectomy, urethroplasty, neovaginal-canal dissection. Stage 2 (separate operation): ~14.3 cm of jejunum harvested via single-port laparoscopy, remodelled, placed in the canal. n = 10; Stage 1 OR 654 min (range 330–920); Stage 2 OR 283 min (range 150–441); no major complications; 2 patients had transient paralytic ileus (resolved within 1 wk); follow-up 6–18 mo.[40]

G. Free vascularized jejunal flap (Ozkan / Turkey) — microsurgical free jejunal flap with anastomosis to recipient vessels (typically inferior epigastric). n = 34, mean follow-up 50 mo; 100% flap survival (3 reoperations for venous compromise, all salvaged); 17.6% (6/34) reported jejunal hypersecretion that gradually diminished after 3 mo; 1 mucosal prolapse; 1 vaginal constriction; 27/34 married and sexually active; FSFI ≥ 25 in 11/20 respondents.[42][44]

Operative parameters (ileal-specific)​

SeriesnApproachOR timeDepth
van der Sluis 2018[37]32 (27 TG, 5 DSD)Open 25 / lap 7288 ± 103 min13.2 ± 3.1 cm
Zhao YZ 2011[41]82Laparoscopic-assisted—15 cm
Trombetta 2005 (Monti)[39]6Open220 min—
Cho 2025 (free jejunal graft)[40]10Lap, 2-stage654 + 283 min—
Ozkan / Akar (free jejunal flap)[42][44]34Open microsurgical—Satisfactory

Ileal-specific complications​

  • Ileal segment necrosis from vascular compromise is the technique-defining catastrophic complication. Karateke 2010 — one of two ileal patients experienced 40 cm of ileal necrosis requiring bilateral ileostomy for 2 months, leading the authors to conclude sigmoid is preferable.[35]
  • van der Sluis 2018 multicentre (n = 32): introital stenosis 12.5% (4/32); recto-neovaginal fistula 3.1% (required temporary ileostomy); iatrogenic bladder injury 3.1%; intraoperative hemorrhage requiring transfusion 3.1%; median hospitalisation 12 d (range 6–30) — longer than sigmoid cohorts.[37]
  • Ozkan free jejunal flap: 17.6% jejunal hypersecretion (gradually diminishes); 8.8% (3/34) venous compromise all salvaged.[42][44]

Mucus secretion — the central trade-off​

Ileal mucosa produces significantly more mucus than colonic mucosa, given higher goblet-cell density and small-bowel secretory physiology.[5][42] The Hensle 23-year bowel-vaginoplasty experience explicitly favoured colonic (particularly sigmoid) over small bowel for this reason.[3] Three technical strategies attenuate the problem:

  1. Terminal-ileum J-pouch (Schneider) — terminal ileum has more balanced resorption / secretion than proximal ileum.[38]
  2. Monti retubularization (Trombetta) — reduces mucosal surface area; 0/6 had excessive mucus.[39]
  3. Time — Ozkan reports hypersecretion gradually diminishes after the first 3 mo.[42]

Current role​

Ileal vaginoplasty occupies a niche role, used predominantly:[37][12]

  • As revision / salvage after failed primary PIV.
  • When sigmoid is unavailable (prior resection, pathology, IBD).
  • When peritoneal-flap salvage has failed or is not feasible.
  • At centres with specific ileal-technique expertise (Trieste, Belgrade, Korea).
  • When anatomic geometry favours the longer ileal mesentery for pedicle reach.

The emergence of robotic peritoneal-flap vaginoplasty as a lower-donor-site-morbidity revision option has further narrowed ileum's role.[12]

Sigmoid Revision Vaginoplasty​

Sigmoid is the most commonly used intestinal technique for revision vaginoplasty after failed primary PIV, with the greatest achievable depth of any revision technique (15.9–17.6 cm), permanent self-lubricating mucosa, and 91–94% success in revision cohorts.[1][14][45]

Indications for sigmoid revision (vs other revision techniques)​

SettingPreferred revision techniqueAnchor
Moderate stenosis with preserved canal spaceRobotic peritoneal-flap revision — first-line: lower morbidity, no bowel anastomosis, 0% rectal injury, 13.6 cm depthDy 2021 NYU n = 24[46]
Complete canal obliterationSigmoid revision — when canal is completely obliterated and insufficient tissue remains for perineal-only revisionvan der Sluis 2016[45]; Sljivich 2025[2]
Failed prior revision (recurrent stenosis after FTSG or peritoneal-flap revision)Sigmoid revisionvan der Sluis 2019 review[12]
Prostato-vaginal or rectovaginal fistulaSigmoid revision addresses fistula and stenosis simultaneouslySljivich 2025 (4 fistula patients)[2]
Max-lubrication prioritySigmoid revision — only revision technique with permanent self-lubrication; peritoneum squamatisesHensle 2006 89% adequate lubrication[3]

Relative contraindications: prior pelvic radiation, sigmoid IBD or diverticular disease, dense pelvic adhesions, significant medical comorbidities precluding abdominal surgery.[5][12]

Technique adaptations specific to revision​

  • Preoperative colonoscopy + abdominal CT — exclude sigmoid pathology and characterise adhesions from prior surgery.[8]
  • Re-entry of the scarred rectovesical space — incise or excise scar tissue to re-establish the canal space.
  • Exaggerated interdigitating colovestibular anastomosis — sigmoid mucosa sutured to perineal skin in interdigitating (zigzag) fashion rather than circumferential end-to-end — distributes tension and prevents introital stenosis at the colo-perineal junction.[6]
  • Sacropromontory neovaginopexy — mandatory prophylactic apex fixation to prevent prolapse (more important in revision context given preexisting anatomic distortion).[6][9]
  • Isoperistaltic (Bouman Amsterdam) vs antiperistaltic (Flor-Lorente) orientation — antiperistaltic may reduce mucus discharge at the introitus.[6][9]
  • ICG fluorescence angiography as safety adjunct — van der Sluis 2019 (n = 6): reconstruction aborted in 1/6 based on inadequate perfusion — potentially preventing flap necrosis; Flor-Lorente 2021 also uses ICG for selective vessel ligation enabling 180° sigmoid rotation while guaranteeing irrigation.[10][9]
  • "Virtual ileostomy" — some groups prepare but do not open a loop ileostomy as a safety measure.[9]

Revision-specific outcomes​

van der Sluis 2016 — the only direct revision-technique head-to-head (n = 53):[45]

OutcomeLaparoscopic intestinal revision (n = 21)Perineal FTSG revision (n = 32)p
Success91% (19/21)81% (26/32)NS
Mean neovaginal depth15.9 ± 1.4 cm12.5 ± 2.8 cm0.01
OR time191 ± 45 min131 ± 35 min0.01
Rectal perforation10% (2/21)19% (6/32)NS
Mortality0%0%—
Median follow-up3.2 yr3.2 yr—

Sljivich 2025 robot-assisted sigmoid revision (n = 25 for stenosis + 4 for fistula):[2]

  • Mean age 36.1 yr; mean OR time 272.9 min; mean LOS 3.7 d.
  • Preoperative depth 3.4 cm (SD 3.3) → postoperative 17.6 cm (SD 3.7) — mean 14.2 cm depth gain.
  • Sigmoid-skin anastomotic stricture 8% (2/25) requiring intervention.
  • 0% new fistula formation; 0% change in bowel habits; 0% persistent vaginitis/discharge > 3 mo; 0% diversion neovaginal colitis on vaginoscopy.
  • Most expressed satisfaction.

Lava 2025 primary-vs-revision comparison (n = 119; 66 primary, 53 revision):[1]

  • OR time was significantly shorter for revision (162 vs 209 min primary, p = 0.001) — likely reflecting that scrotal-skin labial reconstruction and clitoroplasty are not repeated in most revision cases.
  • Short-term complications (30-d) ~17.7% overall — full-thickness dehiscence 8.4%, ileus 5.0%, short-term reoperation 5.0%.
  • Long-term complications (≥ 30-d) ~24.4% — mucosal prolapse 11.8%, introital stenosis 9.2%, long-term reoperation 16.8%.
  • Complication rates were similar between primary and revision cohorts — i.e., prior failed PIV does not meaningfully increase sigmoid-revision morbidity.

Kim 2026 robot-assisted series (n = 12, mostly primary):[8]

  • Mean OR time 544.8 min (substantially longer than Sljivich — likely learning-curve effect).
  • Depth 14.6 cm; vaginal stenosis 0%; positive sexual activity 75%.
  • Overall complication rate 41.7% — ileus 16.7%, prolapse 8.3%, anastomotic leak 8.3%, colon-flap necrosis 8.3% (both Clavien IIIb).

Decision framework: peritoneal-flap vs sigmoid for revision​

The Sljivich 2025 series is the first head-to-head context for these two revision options:

FeatureRobotic peritoneal-flap revision (Dy 2021)Robot-assisted sigmoid revision (Sljivich 2025)
Mean depth13.6 cm17.6 cm
Bowel anastomosisNoYes
Rectal injury0%0%
Sigmoid-skin anastomotic strictureN/A8%
Self-lubricationTransient (mesothelial → squamous metaplasia)Permanent (colonic mucosa)
LOS~ 1 wk3.7 d
Diversion colitisN/A0% on vaginoscopy (Sljivich) but 35–65% endoscopic in older series[16]

Decision rule (synthesised):[1][12][14][45][2]

  • Peritoneal-flap revision = first-line for moderate stenosis with preserved canal — lower morbidity, no bowel anastomosis.
  • Sigmoid revision = preferred for complete obliteration, failed peritoneal-flap salvage, fistula + stenosis combined, or max-lubrication priority.
  • FTSG revision = shortest OR time (131 min) but lowest success (81%), least depth (12.5 cm), highest rectal-perforation rate (19%).

Mortality and major flap-loss signal​

The Robinson 2023 SR identified 2 reported mortalities across 654 intestinal vaginoplasties and 6 cases of vascular compromise leading to flap loss — underscoring that this is a major abdominal procedure with life-threatening potential.[4] The Amsterdam ICG experience (1/6 reconstructions aborted before transposition) is the clearest mechanism for preventing the flap-necrosis pathway.[10]

Obesity and revision-context selection​

Higher-BMI patients may actually be good candidates for sigmoid vaginoplasty (the technique doesn't depend on genital tissue availability). The Lava series had median BMI 28.5 kg/m² with no BMI-driven complication signal; sigmoid may be preferable in BMI patients with limited perineal access.[1]

Complications​

Robinson 2023 SR (10 studies, 654 intestinal vaginoplasties): overall complication rate 33%, average return-to-OR rate 18%.[4]

ComplicationIncidenceNotes
Introital / vaginal stenosis~11%Most common; ~4.1% require surgical correction for sigmoid[1][2]
Mucorrhea (excessive mucus)~7%Persistent; 56% require pads[1][3]
Neovaginal / mucosal prolapse6–11.8%Most common long-term complication[1][4]
Malodor~5%Correlates with inflammatory endoscopic change[1][16]
Full-thickness dehiscence8.4%Short-term (< 30 d)[4]
Ileus / SBO~5%Usually conservative[4][6]
Anastomotic leak (bowel)3.2% (2/63 Amsterdam)Life-threatening; addressed laparoscopically[6]
Rectal perforation4.8% (3/63 Amsterdam)Laparoscopic management; no long-term fistula[6]
Flap necrosis / vascular compromise0.9% (6/654)Devastating; flap loss[1]
Diversion neovaginitis (endoscopic)65%See dedicated section[16]
Mortality2 deaths across 654 casesExtremely rare but documented[1]

Diversion Neovaginitis (Diversion Colitis of the Neovagina)​

A nearly universal complication of sigmoid vaginoplasty, analogous to diversion colitis of any bowel segment surgically diverted from the fecal stream.[16][17]

Pathophysiology. Loss of luminal exposure to short-chain fatty acids (SCFAs) — particularly butyrate — deprives colonocytes of their primary energy source, driving mucosal atrophy, inflammation, and characteristic histologic change.[17][18]

Endoscopic findings (van der Sluis 2016 prospective study, n = 34):[16]

  • 65% with endoscopic inflammation (MAYO ≥ 1) — 35% MAYO 0, 56% MAYO I, 9% MAYO II, 0% MAYO III.
  • Features: diminished vascular pattern, edema, granularity, friability, decreased resilience, erythema.
  • The remaining in-stream rectosigmoid showed no concurrent abnormalities — confirming specificity to the diverted segment.
  • Neovaginal discharge and malodor correlated with inflammatory change.

Histology:[17][11]

  • Lymphocytic infiltration in all biopsies.
  • Acute inflammatory infiltrate in lamina propria in 31% (4/13).
  • Lymphoid follicular hyperplasia; lymphoplasmacellular infiltrates.
  • Spectrum from mild chronic inflammation to active colitis.

Microbiome (van der Sluis 2019):[18]

  • Significantly reduced Bacteroidetes abundance and diversity in the diverted neovaginal segment vs in-stream rectum (Shannon 2.18 vs 2.76).

Management:[19][20][21]

  • SCFA (butyrate) irrigation — addresses the underlying pathophysiology; variable response.
  • Topical mesalamine — Lupo 2024 reports complete symptom resolution in a paediatric case.[19]
  • Topical steroids (suppositories / enemas) — when SCFA fails.[20]
  • Regular douching — discharge and odor control.[3][21]

Ulcerative Colitis in the Sigmoid Neovagina​

Rare but serious complication: de novo UC can develop in the sigmoid neovagina concurrently with the remaining colon, 7–14 years after construction.[22][23][24]

  • Symptoms: bloody vaginal discharge, bloody diarrhea, abdominal pain, weight loss.
  • In severe cases, total proctocolectomy + neovaginectomy is required — colectomy alone is insufficient when the neovaginal segment is also involved.[22]
  • This complication is mechanistically informative: it argues against the hypothesis that UC requires direct exposure to alimentary antigens, since the neovagina is completely diverted from the fecal stream.[24]

Neovaginal Prolapse​

Significant long-term complication in 6–11.8% of sigmoid vaginoplasty patients.[1][4][25][26]

Risk factors: inadequate neovaginopexy at primary surgery; functional elongation during intercourse; inherent colonic redundancy. Osswald 2025 27.5-year follow-up — 1 in 5 transfeminine SRS patients experience genital prolapse, with intestinal neovaginas at the second-highest prevalence (after peritoneal).[26]

Management:[25][27][28][29]

  • Laparoscopic sacrocolpopexy (mesh) — best approach with lowest recurrence; complicated by the need to spare the vascular pedicle.[25][27]
  • Altemeier procedure (vaginal resection) — most definitive vaginal approach; recurrence reported in 3/17 cases.[25]
  • Sacrospinous ligament fixation — alternative vaginal approach.[28]
  • Cooper-ligament suspension — historical approach with reported recurrence.[29]
  • Recurrence rates after repair are higher than previously reported; multidisciplinary approach recommended.[25]

Neoplasia Risk​

Adenocarcinoma arising in a sigmoid neovagina is rare but documented — Dawson-Gore 2025 SR identified 16 case reports over 35 years:[30]

  • 69% (11/16) occurred in sigmoid neovaginas.
  • Symptom onset 7–53 years after reconstruction.
  • Bleeding most common presenting symptom (73%).
  • 50% local disease, 31% locoregional, 6% metastasis at presentation.
  • Most underwent surgical resection (often total pelvic exenteration); 50% experienced recurrence.
  • Histology typically adenocarcinoma (colonic-mucosa origin), in contrast to HPV-related SCC seen in skin-lined neovaginas.[31][32]

Surveillance — no formal screening guidelines exist:[30][31][32][33]

  • Annual gynecologic exam with speculum.
  • Some experts advocate periodic neovaginoscopy with biopsy, particularly > 10 years post-construction.
  • HPV screening may be warranted for the skin-lined introital portion.

Functional and Sexual Outcomes​

Lubrication. The sigmoid neovagina provides persistent, durable self-lubrication from mucus-secreting colonic mucosa. Hensle 23-year experience: 89% report adequate lubrication for intercourse — but 56% require pads for mucus and 94% use home douching.[3]

Hensle sexual function (n = 36, mean 8.8-yr follow-up):[3]

  • 78% sexual desire and satisfaction.
  • 56% frequent orgasms; 22% occasional; 22% no orgasms.
  • 33% reported sexual arousal and confidence.
  • Only 2 patients reported dyspareunia.

di Summa 2019 (n = 43) — sigmoid as secondary procedure significantly decreased sexual pain during intercourse vs PIV; aesthetic / functional outcomes similar with mostly satisfied patients; better functional outcomes than PIV with similar cosmetic results.[14]

Yinuo 2025 (peritoneal vs sigmoid in MRKH, the first direct comparison) — peritoneal showed shorter OR, faster recovery, shorter mold use, and higher sexual satisfaction vs sigmoid; no difference in blood loss, hospital stay, or discharge odor. Cisgender cohort — generalisability to transfeminine GAS limited.[34]

Postoperative Care​

Differs from PIV in several ways:[8][21][1]

Immediate: stent 3–7 d; Foley; bed rest; DVT prophylaxis; antibiotics; NPO → graded diet as bowel function returns; some protocols use VAC dressing.[8]

Dilation: required but less intensive than after PIV — colonic mucosa is more resistant to stenosis than skin.[1] Introital stenosis remains the most common complication requiring intervention (9.2–11%).[1][4] Karateke 2010 — unmarried / sexually inactive patients had 79% stenosis vs 0% in sexually active patients.[35]

Long-term:

  • Regular douching essential — 94% of Hensle cohort use home douching for mucus and odor management.[3]
  • Pads for mucus in 56%.[3]
  • Annual neovaginoscopy recommended by some centers for diversion-neovaginitis and neoplasia surveillance.[16][30]
  • Prostate examinations performed vaginally (anterior to neovagina).[21]

Comparison Across Full-Depth Techniques​

FeatureIntestinalPeritonealPIV (skin-lined)
Depth14–17.6 cm~14 cm10–14 cm (tissue-dependent)
Self-lubricationPersistent (colonic mucosa)Transient (squamous metaplasia)None
DilationLess intensiveStandardIntensive, lifelong
Donor-site morbiditySignificant (bowel anastomosis)MinimalNone
Mucus / odorCommon (mucorrhea 7%, malodor 5%)MinimalNone
Diversion colitis65% endoscopicNoNo
Prolapse6–11.8%Higher in long-term cohortsLowest
Neoplasia riskDocumented adenocarcinomaUnknown (too new)Rare HPV-SCC
Operative complexityHigh (requires colorectal surgeon)High (robotic expertise)Moderate
OR time162–545 min125–262 min150–300 min
Overall complication rate~33%~15%20–70%
Mortality2 reported across 654 cases0 reported0 reported

Anchors: Lava 2025[1]; Sljivich 2025[2]; Hensle 2006[3]; Robinson SR[4]; Morrison 2023 review[36]; Osswald 2025[26]; Yinuo 2025[34]; Dawson-Gore 2025[30]; van der Sluis diversion[16].

Advantages and Disadvantages​

AdvantagesDisadvantages
Persistent self-lubrication (no metaplasia)[1][3]Significant donor-site morbidity (bowel resection + anastomosis)[8][4]
Consistent 14–17 cm depth[8][2]Mucorrhea (7%), malodor (5%), pads (56%), douching (94%)[3][4]
Reduced dilation requirements[1]Diversion neovaginitis nearly universal (65% endoscopic)[16]
Hairless canal[13]Prolapse 6–11.8%; complex repair pathway[1][25]
Durable, well-vascularised mucosa[5]Documented late adenocarcinoma; no screening guidelines[30]
Effective salvage for failed PIV with comparable outcomes to primary cases[1]Rare de novo UC in the neovaginal segment[22][23]
Multidisciplinary team including colorectal surgeon required[6][12]
Longer OR times (up to 545 min robotic)[8]
Mortality — 2 deaths across 654 cases[1]

Evidence Limitations​

The evidence base is dominated by retrospective single-centre case series with heterogeneous techniques, variable follow-up, and non-standardised outcome measures.[4][5] No RCTs compare intestinal vaginoplasty to PIV or peritoneal vaginoplasty. The Bouman 2014 SR (21 included studies) noted all were retrospective and low-quality, with sexual satisfaction rarely assessed using standardised questionnaires and QoL not reported.[5] The Yinuo 2025 comparison of peritoneal vs sigmoid is the first direct head-to-head but was performed in cisgender MRKH — generalisability to transfeminine GAS is limited.[34] Long-term surveillance protocols for neoplasia and diversion colitis remain undefined.[30]

References​

1. Lava CX, Ferdousian S, Li KR, et al. Outcomes of gender-affirming sigmoid colon vaginoplasty: a retrospective study of 119 patients. J Plast Reconstr Aesthet Surg. 2025;106:310–318. doi:10.1016/j.bjps.2025.04.041

2. Sljivich M, Torres C, Chen D, et al. Feasibility and outcomes after robot-assisted sigmoid vaginoplasty for gender dysphoria. Urology. 2025. doi:10.1016/j.urology.2025.06.003

3. Hensle TW, Shabsigh A, Shabsigh R, Reiley EA, Meyer-Bahlburg HF. Sexual function following bowel vaginoplasty. J Urol. 2006;175(6):2283–2286. doi:10.1016/S0022-5347(06)00337-5

4. Robinson IS, Cripps CN, Bluebond-Langner R, Zhao LC. Operative management of complications following intestinal vaginoplasty: a case series and systematic review. Urology. 2023;180:105–112. doi:10.1016/j.urology.2023.07.005

5. Bouman MB, van Zeijl MC, Buncamper ME, et al. Intestinal vaginoplasty revisited: a review of surgical techniques, complications, and sexual function. J Sex Med. 2014;11(7):1835–1847. doi:10.1111/jsm.12538

6. Bouman MB, Buncamper ME, van der Sluis WB, Meijerink WJ. Total laparoscopic sigmoid vaginoplasty. Fertil Steril. 2016;106(7):e22–e23. doi:10.1016/j.fertnstert.2016.08.049

7. Kim JK, Na W, Cho JH, et al. Refinement of recto-sigmoid colon vaginoplasty using a three-dimensional laparoscopic technique. Medicine (Baltimore). 2021;100(35):e27042. doi:10.1097/MD.0000000000027042

8. Kim KH, Kim KH, Hwang NH, et al. Gender-affirming robot-assisted sigmoid vaginoplasty: outcomes and complications from a retrospective review of 12 cases. Medicine (Baltimore). 2026;105(9):e47849. doi:10.1097/MD.0000000000047849

9. Flor-Lorente B, Rosciano JG, Pérez-Pérez T, et al. Gender dysphoria: laparoscopic sigmoid vaginoplasty. Another utility of indocyanine green. Colorectal Dis. 2021;23(12):3272–3275. doi:10.1111/codi.15952

10. van der Sluis WB, Bouman MB, Al-Tamimi M, Meijerink WJ, Tuynman JB. Real-time indocyanine green fluorescent angiography in laparoscopic sigmoid vaginoplasty to assess perfusion of the pedicled sigmoid segment. Fertil Steril. 2019;112(5):967–969. doi:10.1016/j.fertnstert.2019.08.063

11. van der Sluis WB, Neefjes-Borst EA, Bouman MB, et al. Morphological spectrum of neovaginitis in autologous sigmoid transplant patients. Histopathology. 2016;68(7):1004–1012. doi:10.1111/his.12894

12. van der Sluis WB, Tuynman JB, Meijerink WJHJ, Bouman MB. Laparoscopic intestinal vaginoplasty in transgender women: an update on surgical indications, operative technique, perioperative care, and short- and long-term postoperative issues. Urol Clin North Am. 2019;46(4):527–539. doi:10.1016/j.ucl.2019.07.007

13. Bene NC, Ferrin PC, Xu J, et al. Tissue options for construction of the neovaginal canal in gender-affirming vaginoplasty. J Clin Med. 2024;13(10):2760. doi:10.3390/jcm13102760

14. di Summa PG, Watfa W, Krähenbühl S, et al. Colic-based transplant in sexual reassignment surgery: functional outcomes and complications in 43 consecutive patients. J Sex Med. 2019;16(12):2030–2037. doi:10.1016/j.jsxm.2019.09.007

15. Garcia MM, Shen W, Zhu R, et al. Use of right colon vaginoplasty in gender affirming surgery: proposed advantages, review of technique, and outcomes. Surg Endosc. 2021;35(10):5643–5654. doi:10.1007/s00464-020-08078-2

16. van der Sluis WB, Bouman MB, Meijerink WJHJ, et al. Diversion neovaginitis after sigmoid vaginoplasty: endoscopic and clinical characteristics. Fertil Steril. 2016;105(3):834–839.e1. doi:10.1016/j.fertnstert.2015.11.013

17. Toolenaar TA, Freundt I, Huikeshoven FJ, et al. The occurrence of diversion colitis in patients with a sigmoid neovagina. Hum Pathol. 1993;24(8):846–849. doi:10.1016/0046-8177(93)90134-3

18. van der Sluis WB, Bouman MB, Mullender MG, et al. The effect of surgical fecal stream diversion of the healthy colon on the colonic microbiota. Eur J Gastroenterol Hepatol. 2019;31(4):451–457. doi:10.1097/MEG.0000000000001330

19. Lupo AM, Lawson AA, Rentea RM, Kapalu CL, Rosen JM. Intravaginal mesalamine administration: a novel technique for neovaginal colitis. J Pediatr Adolesc Gynecol. 2024;37(1):93–94. doi:10.1016/j.jpag.2023.08.006

20. Syed HA, Malone PS, Hitchcock RJ. Diversion colitis in children with colovaginoplasty. BJU Int. 2001;87(9):857–860. doi:10.1046/j.1464-410x.2001.02180.x

21. Jackson Q, Yedlinsky NT, Gray M. Lifelong care of patients after gender-affirming surgery. Am Fam Physician. 2024;109(6):560–565.

22. Webster T, Appelbaum H, Weinstein TA, et al. Simultaneous development of ulcerative colitis in the colon and sigmoid neovagina. J Pediatr Surg. 2013;48(3):669–672. doi:10.1016/j.jpedsurg.2012.12.025

23. Sadeghi A, Bahrami Hezaveh E, Ali Asgari A. Ulcerative colitis in a transgender woman with a sigmoid neovagina: a case report. Int J Colorectal Dis. 2024;39(1):103. doi:10.1007/s00384-024-04676-x

24. Froese DP, Haggitt RC, Friend WG. Ulcerative colitis in the autotransplanted neovagina. Gastroenterology. 1991;100(6):1749–1752. doi:10.1016/0016-5085(91)90679-f

25. Drusany Starič K, Distefano REC, Norčič G. Sigmoid neovagina prolapse treated with Altemeier procedure: case report and systematic review of the literature. Int Urogynecol J. 2023;34(11):2647–2655. doi:10.1007/s00192-023-05603-4

26. Osswald R, Villiger AS, Ruggeri G, et al. Twenty-seven years after sex reassignment surgery in female transgender patients: is prolapse of the neovagina an issue? Int Urogynecol J. 2025;36(9):1819–1825. doi:10.1007/s00192-025-06251-6

27. Ayumba A, Nomura M, Hayashi T. Laparoscopic sacrocolpopexy as an effective treatment for late sigmoid neovagina prolapse with colonic polyps. Int Urogynecol J. 2026;37(4):1085–1089. doi:10.1007/s00192-025-06369-7

28. Henninger V, Reisenauer C, Brucker SY, Rall K. Laparoscopic nerve-preserving colposacropexy for surgical management of neovaginal prolapse. J Pediatr Adolesc Gynecol. 2015;28(5):e153–e155. doi:10.1016/j.jpag.2014.12.005

29. Freundt I, Toolenaar TA, Jeekel H, Drogendijk AC, Huikeshoven FJ. Prolapse of the sigmoid neovagina: report of three cases. Obstet Gynecol. 1994;83(5 Pt 2):876–879.

30. Dawson-Gore CC, Evans L, Vincent S, et al. The need for screening recommendations after intestinal vaginal replacement: a systematic review of the literature. Pediatr Surg Int. 2025;41(1):172. doi:10.1007/s00383-025-06081-z

31. Fedele F, Bulfoni A, Parazzini F, Busnelli A. Neovagina creation methods in Müllerian anomalies and risk of malignancy: insights from a systematic review. Arch Gynecol Obstet. 2024;309(3):801–812. doi:10.1007/s00404-023-07086-6

32. Lang SM, Reddy RA, Renz M. Neovaginal human papilloma virus–related squamous cell carcinoma in a transgender woman. JAMA Netw Open. 2024;7(3):e242537. doi:10.1001/jamanetworkopen.2024.2537

33. Steiner E, Woernle F, Kuhn W, et al. Carcinoma of the neovagina: case report and review of the literature. Gynecol Oncol. 2002;84(1):171–175. doi:10.1006/gyno.2001.6417

34. Yinuo L, Zihan L, Xiaorui L, et al. Comparative study of laparoscopic peritoneal vaginoplasty versus sigmoid colon vaginoplasty in the treatment of congenital absence of vagina. Surg Endosc. 2025. doi:10.1007/s00464-025-11868-1

35. Karateke A, Haliloglu B, Parlak O, Cam C, Coksuer H. Intestinal vaginoplasty: seven years' experience of a tertiary center. Fertil Steril. 2010;94(6):2312–2315. doi:10.1016/j.fertnstert.2010.01.004

36. Morrison SD, Claes K, Morris MP, et al. Principles and outcomes of gender-affirming vaginoplasty. Nat Rev Urol. 2023;20(5):308–322. doi:10.1038/s41585-022-00705-y

37. van der Sluis WB, Pavan N, Liguori G, et al. Ileal vaginoplasty as vaginal reconstruction in transgender women and patients with disorders of sex development: an international, multicentre, retrospective study on surgical characteristics and outcomes. BJU Int. 2018;121(6):952–958. doi:10.1111/bju.14155

38. Schneider W, Nguyen-Thanh P, Dralle H, Mirastschijski U. Ileal J-pouch vaginoplasty: reconstruction of a physiologic vagina with an ileal J-pouch. Am J Obstet Gynecol. 2009;200(6):694.e1–694.e4. doi:10.1016/j.ajog.2009.03.009

39. Trombetta C, Liguori G, Siracusano S, Bortul M, Belgrano E. Transverse retubularized ileal vaginoplasty: a new application of the Monti principle — preliminary report. Eur Urol. 2005;48(6):1018–1023; discussion 1023–1024. doi:10.1016/j.eururo.2005.05.006

40. Cho E, Kim J, Yoon ES, Kunaporn S, Hwang NH. Free jejunal graft vaginoplasty in gender affirmation surgery: a novel technique. Aesthet Plast Surg. 2025. doi:10.1007/s00266-025-05201-3

41. Zhao YZ, Jiang H, Liu AT, et al. Laparoscope-assisted creation of a neovagina using pedicled ileum segment transfer. World J Surg. 2011;35(10):2315–2322. doi:10.1007/s00268-011-1187-3

42. Erman Akar M, Özkan Ö, Özkan Ö, Colak T, Gecici O. Sexual function and long-term results following vaginal reconstruction with free vascular jejunal flap. J Sex Med. 2013;10(11):2849–2854. doi:10.1111/jsm.12274

43. Liguori G, Trombetta C, Bucci S, et al. Laparoscopic mobilization of neovagina to assist secondary ileal vaginoplasty in male-to-female transsexuals. Urology. 2005;66(2):293–298; discussion 298. doi:10.1016/j.urology.2005.03.091

44. Ozkan O, Akar ME, Ozkan O, et al. The use of vascularized jejunum flap for vaginal reconstruction: clinical experience and results in 22 patients. Microsurgery. 2010;30(2):125–131. doi:10.1002/micr.20713

45. van der Sluis WB, Bouman MB, Buncamper ME, Mullender MG, Meijerink WJ. Revision vaginoplasty: a comparison of surgical outcomes of laparoscopic intestinal versus perineal full-thickness skin graft vaginoplasty. Plast Reconstr Surg. 2016;138(4):793–800. doi:10.1097/PRS.0000000000002598

46. Dy GW, Blasdel G, Shakir NA, Bluebond-Langner R, Zhao LC. Robotic peritoneal flap revision of gender-affirming vaginoplasty: a novel technique for treating neovaginal stenosis. Urology. 2021;154:308–314. doi:10.1016/j.urology.2021.03.024